To determine which class of HDACs functions in the transcription of SEMA3E, three gastric cancer cell lines were treated with the following class-specific HDAC inhibitors: class I HDAC inhibitor mocetinostat (MGCD0103) or class II HDAC inhibitor MC1568. Here, SEMA3E is linked to gastric cancer.